.

Pharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Lisinopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for lisinopril?

Lisinopril is the generic ingredient in four branded drugs marketed by Silvergate Pharms, Apotex Inc, Wockhardt, Sandoz, Invagen Pharms, Lupin, Aurobindo, Prinston Inc, Sun Pharm Inds Ltd, Ivax Sub Teva Pharms, Accord Hlthcare, Merck, Watson Labs, Hikma Intl Pharms, Mylan, Alvogen Malta, and Teva, and is included in twenty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for lisinopril. Eighty suppliers are listed for this compound.

Summary for Generic Name: lisinopril

Tradenames:4
Patents:2
Applicants:17
NDAs:21
Drug Master File Entries: see list21
Suppliers / Packagers: see list80
Bulk Api Vendors: see list42
Clinical Trials: see list34
Patent Applications: see list6,833
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lisinopril at DailyMed

Pharmacology for Ingredient: lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc
LISINOPRIL
lisinopril
TABLET;ORAL076180-002Jul 1, 2002RXNoNo► Subscribe► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-002Dec 29, 1987RXNoNo► Subscribe► Subscribe
Apotex Inc
LISINOPRIL
lisinopril
TABLET;ORAL076102-006Sep 30, 2002RXNoNo► Subscribe► Subscribe
Watson Labs
LISINOPRIL
lisinopril
TABLET;ORAL076059-003Jul 1, 2002RXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
LISINOPRIL
lisinopril
TABLET;ORAL075944-004Jul 1, 2002RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-006Jan 28, 19944,374,829*PED► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-002Dec 29, 19874,374,829*PED► Subscribe
Alvogen Malta
ZESTRIL
lisinopril
TABLET;ORAL019777-002May 19, 19884,374,829*PED► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-003Dec 29, 19874,374,829*PED► Subscribe
Merck
PRINIVIL
lisinopril
TABLET;ORAL019558-001Dec 29, 19874,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc